| || |
|Page 1 of 1 || Previous | Next |
| | SCIENCE DAILY
DECEMBER 23, 2014 [Lactic Acidosis] Popular diabetes drug may be safe for patients with kidney disease
Despite its strong safety profile, the FDA has long recommended that metformin not be prescribed to patients with mild to moderate kidney disease due to the risk of lactic acidosis, a potentially serious condition. The most popular treatment for type 2 diabetes, metformin, may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new, systematic review of the literature. For 20 years, metformin has been used in the U.S.
| || |